[Endothelin].
Shirai
Kenichi
K
Division of Kidney and Dialysis, Department of Internal Medicine, Hyogo College of Medicine.
Nakanishi
Takeshi
T
Takamitsu
Yoshihiro
Y
D058186:Acute Kidney Injury / Q000209:etiology; D000818:Animals; D015415:Biomarkers; D003287:Contrast Media / Q000009:adverse effects; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000737:chemistry / Q000378:metabolism / Q000502:physiology; D019446:Endotoxemia / Q000209:etiology; D004921:Erythropoietin / Q000009:adverse effects; D005355:Fibrosis / Q000209:etiology; D006020:Glycopeptides; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism; D010456:Peptides, Cyclic; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010537:Peritoneum / Q000473:pathology; D011379:Prognosis; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects
D015415:Biomarkers; D003287:Contrast Media; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D006020:Glycopeptides; D010456:Peptides, Cyclic; D011994:Recombinant Proteins; D004921:Erythropoietin; C072247:cyclo(Trp-Asp-Pro-Val-Leu); C008890:phosphoramidon